P r o t e i n C (PC) is a u n i q u e v i t a m i n K d e p e n d e n t plasma p r o t e i n which a c t s a s a n a n t i c o a g u l a n t . Thromboembolism h a s b e e n r e p o r t e d i n k i n d r e d s w i t h PC l e v e l s which a r e c o n g e n i t a l l y 38-60% o f n o r m a l . PC was measured by e l e c t r oimmunoassay i n 47 n e o n a t e s r a n g i n g i n g e s t a t i o n a l a g e (GA) f r o m 28-40 weeks. None had e v i d e n c e of DIC; a l l had r e c e i v e d v i t a m i n K. On day 1 o f l i f e mean PC was 27% f 2.9 SEM ( r a n g e < l O t o 67%) o f t h e normal a d u l t mean. PC c o r r e l a t e d w i t h GA i n t h e 22 i n f a n t s who were h e a l t h y ( r = . 6 5 p < . 0 1 ) b u t d i d n o t c o r r e l a t e i n t h e 25 s i c k i n f a n t s .
P o s t n a t a l l y PC was 32% o n day 7 a n d 31% on day 28. None of t h e i n f a n t s had e v i d e n c e o f thromboembolism. c a w r e d u c e d t h e e l e c t r o p h o r e t i c m o b i l i t y o f i n f a n t s ' PC i n d i c a t i n g t h a t i t w a s Y c a r b o x y l a t e d .
I t i s c o n c l u d e d t h a t 1 ) For a t l e a s t t h e f i r s t 28 d a y s o f l i f e ,
PC was below t h e r a n g e r e p o r t e d i n k i n d r e d s w i t h c o n g e n i t a l d e f i c i e n c y a n d thromboembolism, y e t thromboembolism d i d n o t o c c u r i n t h e s e n e o n a t e s . 2) PC i n t h e newborn i s y c a r b o x yl a t e d i n d i c a t i n g t h a t t h e low l e v e l s a r e d u e t o d e c r e a s e d s y n t h e s i s a n d / o r s h o r t h a l f l i f e . 3 ) PC l e v e l s i n h e a l t h y newborns c o r r e l a t e s w i t h GA. Last year, Tarnous (Ped Research #1183) reported plasm c h m t a c t i c inhibitors in h m p h i l i a c s receiving Factor VIII concentrates. To confirm this finding,and to assess total granulocyte function we tested 11 severe hemophiliacs 21-64 years old (mdian 25) (8 on Factor VIII and 3 on cryo). All had n o m l T and B c e l l n u h e r s but significantly decreased T /T ratios 0 . The e f f e c t s o f two h o u r s o f f e t a l a c i d o s i s (mean pH 6 . 9 3 ) on f e t a l and m a t e r n a l b l o o d c o a g u l a t i o n w e r e m e a s u r e d . C o a g u l a t i o n t e s t r e s u l t s from 1 0 f e t a l lambs and m o t h e r ewes (127 t 2 d a y s mean g e s t a t i o n ) b e f o r e and a f t e r f e t a l l a c t i c a c i d i n f u s i o n w e r e compared w i t h t e s t r e s u l t s from 8 c o n t r o l f e t a l lambs and m o t h e r ewes (127 + 3 d a y s mean g e s t a t i o n ) b e f o r e and a f t e r c o n t r o l g l uc o s e i n f u s i o n . T e s t s i n c l u d e d Hb, H c t , WBC, p l a t e l e t c o u n t , pH, pC02, pOZ, PT, PTT, t h r o m b i n t i m e , f i b r i n o g e n , f a c t o r s 11, V, V I I , V I I I , IX, X, XI, XI1 a c t i v i t i e s , f i b r i n monomer (FM), A T I I I , a n d FDP l e v e l s . S i g n i f i c a n t c h a n g e s i n a c i d o t i c f e t a l lambs n o t s e e n i n c o n t r o l s i n c l u d e d i n c r e a s e d WBC (mean 2800/mm3 t o 3600/mm3; p=.0009), s h o r t e n e d t h r o m b i n t i m e (mean 1 7 . 8 s e c t o 1 1 . 2 s e c ; p = . 0 0 0 1 ) , d e c r e a s e d f a c t o r V (mean 57% t o 37%; p=.0014), f a c t o r IX (mean 35% t o 29%; p = . 0 1 2 8 ) , and f i b r i n o g e n (mean 1 4 7 mg % t o 1 2 5 mg % ; p=.0492).
T h e r e w e r e no i n c r e a s e s i n FX o r FDP and no d e c r e a s e s i n latel let c o u n t s o r AT 111 l e v e l s .
A l t h o u g h t h e r e was no change i n pH o r l a c t a t e , a d e c r e a s e i n f a c t o r V was found i n ewes w i t h a c i d o t i c f e t u s e s (mean 141% t o 113%; p=.006) and a d e c r e a s e i n f a c t o r IX (mean 119% t o 102%) a p p r o a c h e d s i g n i f i c a n c e ( p = . 0 5 6 P-VALUE c i e n t s u s i n g c o n c e n t r a t e s . Those u s i n g c r y o p r e c i p i t a t e and F-P c e l l s P s e m 21.711.9.88% C c e l l s C s e w 24.5618.72% NS IX s u b j e c t s had t i t e r s c o m p a r a b l e t o c o n t r o l s . I n s u b j e c t s r e -P c e l l s P senm 21.82110.4X
) . F e t a l a c i d o s i s t h u s i n d u c e s a h y p e r c o a g u l a b l e s t a t e i n t h e f e t u s by s h o r t e n i n g t h e t h r o m b i n t i m e . D e c r e a s e s i n t h e l e v e l s o f f a c t o r V and IX a r e a l s o obs e r v e d i n b o t h f e t u s and m o t h e r , s u g g e s t i n g t h e
P c e l l s C senm 21.96113.9% 
NS c e i v i n g c o n c e n t r a t e , t h e t i t e r s d i d n o t c o r r e l a t e w i t h f a c t o r

t a c t i c activitv when t e d i n 28% o f h e m o p h i l i a c s w i t h anti-HTLV-MA t i t e r s <1:20, 44%
-..
n o m l donor c e l l s wre incubated with c m r i c a l Factor VIII ~reoarations. Thus w i t h t i t e r s = l : 4 0 , and i n 100% w i t h t i t e r s > 1 : 7 5 s u g g e s t i n g a n
. .
in h m o h i l i a c s with a b n o m l cellular imnunitv we were unable t o d m n s t r a t e any a s s o c i a t i o n . No c o r r e l a t i o n was found between Tq/T8 r a t i o s and cellular or s e m defects i n d i m t a x i s or in other granulocyte functions.
A larger series of patients will be studied to confirm this.
HEMOLYTIC TRANSFUSION REACTION (HTR) ASSOCIATED WITH
INmAVENOUS IMMUNE GLOBULIN (IV I g
) . Haewon C. Kim, C. Lucy P a r k , James H. Cowan, 111, F r a n c i s F a t t o r i , C h a r l e s S. A u g u s t , Univ. of Penn. a n d C h i l d r e n ' s Hosp. o f P h i l a . D e p t s . o f P e d i a t r . a n d C l i n . Labs.
High d o s e IV I g h a s b e e n t r i e d i n immune c y t o p e n i a ( s ) w i t h few c o m p l i c a t i o n s .
We r e p o r t a s e v e r e HTR d u e t o IV I g . A 1 0 y ro l d B Rho(D) p o s . boy who r e c e i v e d a bone marrow t r a n s p l a n t (BMT) f r o m h i s 0 Rho(D) n e g . s i s t e r was g i v e n IV I g (C51911, GAMIMLTNE, 5 % , C u t t e r Lab.) f o r p l a t e l e t a l l o i m m u n i z a t i o n . On d a y 9 p o s t -BMT h e d e v e l o p e d a c h i l l a n d h y p o t e n s i o n a f t e r 1 2 0 ml o f IV I g a n d h e m o g l o b i n u r i a l a t e r . On day 1 0 h e had a s e v e r e s h a k i n g c h i l l a f t e r 1 0 0 ml o f IV I g and symptoms r e c u r r e d a f t e r 2 ml of i n f us i o n . On d a y s 1 0 t o 12 h e had h y p e r b i l i r u b i n e m i a ( 4 . 5 m g l d l ) , hemoglobinemia ( 9 8 m g / d l ) , h e m o g l o b i n u r i a ( 7 5 mg/dl) and no hapt o g l o b i n . Hb r e m a i n e d between 6-7 g / d l w i t h 8 u n i t s o f RBC. On day 1 3 u r i n e became c l e a r and Hb r o s e w i t h o u t t r a n s f u s i o n s (Tx). No Tx w e r e g i v e n 48 h r s . pre-IV I g . A f t e r BMT h e was g i v e n 0 n e g . d e g l y c e r o l i z e d -R B C a n d g r o u p B plasma a n d p l a t e l e t s . Pre-IV I g h e was B p o s . a n d had a n e g a t i v e d i r e c t a n t i g l o b u l i n t e s t (ACT) a n d a n t i b o d y s c r e e n . Post-IV I g d i r e c t a n d i n d i r e c t AGT w e r e p o s i t i v e ( d a y s 10-13); a n t i -B ( l : 4 ) was d e t e c t e d i n h i s s e r a from day 1 2 . S e r a and e l u a t e d e m o n s t r a t e d a n t i g l o b u l i n r e a c t i v i t y w i t h group B RBC. The IV I g he r e c e i v e d had 1 : 6 4 f o r a n t i -B a n d Anti-A. On day 1 6 , p a t i e n t was t y p e d a s 0 n e g . To e v a l u a t e CSF B2M a s a m a r k e r o f CNS l e u k e m i a , B2M was measu r e d i n t h e CSF (N=485) and serum (N=178) o f 58 c h i l d r e n w i t h ALL o v e r a 34 month p e r i o d . CSF B2M a n d / o r t h e CSF/serum B2M r a t i o w e r e i n c r e a s e d i n p a t i e n t s w i t h b l a s t c e l l s on c y t o s p i n , p r e v i o u s CNS d i s e a s e i n r e m i s s i o n , o v e r t CNS i n v o l v e m e n t , t h e somnolence syndrome and r e c e n t i n t r a t h e c a l m e t h o t r e x a t e ( p < . 0 0 5 ) . CSF B2M i n c r e a s e d w i t h , b u t n o t p r i o r t o , t h e development o f o v e r t CNS d i s e a s e a n d peaked 3-4 weeks t h e r a f t e r (N=4 p a t i e n t s ) . To e v a l ua t e CSF B2M a s a m a r k e r of t h e r a p y -r e l a t e d CNS i n j u r y , 1 5 pat i e n t s w i t h o u t CNS i n v o l v e m e n t w e r e s t u d i e d s e r i a l l y f o r 20 t o 8 0 weeks from d i a g n o s i s .
CSF B2M i n c r e a s e d f o l l o w i n g i n t r a t h e c a l m e t h o t r e x a t e a l o n e (weeks 0 t o 4) from 0 . 5 5 t . 4 4 t o 0 . 7 7 ? . 5 4 m g / l ( p f . 0 1 ) .
F o l l o w i n g c r a n i a l i r r a d i a t i o n (weeks 4 t o 6 ) , CSF B2M i n c r e a s e d f u r t h e r t o 1 . 0 0 t . 7 3 m g l l (pc.OOl), and peaked a f t e r s i x weeks. A s e c o n d peak ( 2 . 1 4 t 1 . 4 7 m g / l ) was o b s e r v e d a f t e r 26 weeks. CSF B2M r e t u r n e d t o w a r d s p r e -t h e r a p y l e v e l s by t h e end of t h e f i r s t y e a r . I t i s c o n c l u d e d t h a t CSF B2M i n c r e a s e s i n r es p o n s e t o o v e r t b u t n o t o c c u l t CNS l e u k e m i a and t o t h e r a p y -r e l at e d CNS i n j u r y . The l a t t e r f o l l o w s a p r e d i c t a b l e bi-modal c u r v e f o l l o w i n g c r a n i a l i r r a d i a t i o n and i n t r a t h e c a l m e t h o t r e x a t e d u r i n g t h e f i r s t y e a r of t r e a t m e n t . S t u d i e s d e m o n s t r a t i n g p r o d u c t i o n o f B2M by e n d o t h e l i a l c e l l s i n c u l t u r e s u g g e s t t h a t t h e s o u r c e of t h e e l e v a t e d CSF B2M s e e n f o l l o w i n g CNS t h e r a p y , i n t h e a b s e n c e of o v e r t CNS l e u k e m i a , may b e v a s c u l a r .
